Carl Zeiss Meditec AG (LON: 0DHC)

Market Cap	3.66B
Revenue (ttm)	1.72B
Net Income (ttm)	148.73M
Shares Out	n/a
EPS (ttm)	1.67
PE Ratio	24.64
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Mar 22, 2024

Volume	110,525
Average Volume	13,740
Open	48.49
Previous Close	48.73
Day's Range	48.22 - 49.74
52-Week Range	37.27 - 102.13
Beta	1.04
RSI	52.71
Earnings Date	Feb 12, 2025

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1846
• Employees: 5,730
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0DHC

Financial Performance

In 2024, Carl Zeiss Meditec AG's revenue was 2.07 billion, a decrease of -1.11% compared to the previous year's 2.09 billion. Earnings were 178.73 million, a decrease of -38.45%.

Financial numbers in EUR